The research teams want to get their drug approved so it can help many people. This means proving it is safe and effective.

Unfortunately, using it in a non-study context risks a whole lot of confusion-- if the marginal, near-death case that wouldn't qualify for your trial dies in a weird way, what do you do?

Not to mention that prior to approval, there are no economies of scale in production.